USE OF ANATABINE FOR REDUCING BLOOD SERUM LEVELS OF C-REACTIVE PROTEIN IN AN INDIVIDUAL Application EP-3871674-A1 European Patent Office 01 Sep 2021
USE OF ANATABINE TO TREAT INFLAMMATION AND METHODS OF SYNTHESIZING ANATABINE Application EP-3524246-A1 European Patent Office 14 Aug 2019
USE OF ANATABINE TO TREAT INFLAMMATION AND METHODS OF SYNTHESIZING ANATABINE Application EP-3524245-A1 European Patent Office 14 Aug 2019
Pharmaceutical, dietary supplement, and food grade salts of anatabine Grant US-8557999-B2 United States of America 15 Oct 2013